Aventis Pharma Profit & Loss account, Aventis Pharma Financial Statement & Accounts

YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Aventis Pharma

Aventis Pharma

BSE: 500674|NSE: AVENTIS|ISIN: INE058A01010|SECTOR: Pharmaceuticals

SET ALERT

LIVE

BSE

Feb 14, 15:25

2290.00

81.05 (3.67%)

VOLUME 486

LIVE

NSE

Feb 14, 15:23

2300.00

101.95 (4.64%)

VOLUME 1,820

SHAREHOLDING PATTERN

Previous Years �

Standalone

Profit & Loss account of Aventis Pharma

------------------- in Rs. Cr. -------------------

	Dec '10	Dec '09	Dec '08	Dec '07	Dec '06

	12 mths	12 mths	12 mths	12 mths	12 mths

Income
Sales Turnover	1,166.08	1,048.23	1,065.43	957.69	946.30
Excise Duty	24.17	20.96	34.09	67.66	54.56
Net Sales	1,141.91	1,027.27	1,031.34	890.03	891.74
Other Income	125.42	49.18	53.12	42.96	34.69
Stock Adjustments	16.74	61.89	-22.36	18.26	22.37
Total Income	1,284.07	1,138.34	1,062.10	951.25	948.80
Expenditure
Raw Materials	557.08	546.79	467.69	442.48	453.13
Power & Fuel Cost	21.08	19.50	20.42	15.59	13.39
Employee Cost	163.25	143.95	119.20	103.72	78.51
Other Manufacturing Expenses	36.45	30.33	25.32	24.63	26.22
Selling and Admin Expenses	135.86	119.03	145.53	86.96	76.53
Miscellaneous Expenses	39.98	28.80	8.63	41.37	33.28
Preoperative Exp Capitalised	0.00	0.00	0.00	0.00	0.00
Total Expenses	953.70	888.40	786.79	714.75	681.06
	Dec '10	Dec '09	Dec '08	Dec '07	Dec '06

	12 mths	12 mths	12 mths	12 mths	12 mths

Operating Profit	204.95	200.76	222.19	193.54	233.05
PBDIT	330.37	249.94	275.31	236.50	267.74
Interest	2.89	0.07	0.34	0.19	0.18
PBDT	327.48	249.87	274.97	236.31	267.56
Depreciation	19.74	17.34	18.21	18.45	17.85
Other Written Off	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	307.74	232.53	256.76	217.86	249.71
Extra-ordinary items	-10.28	7.50	2.89	3.94	0.00
PBT (Post Extra-ord Items)	297.46	240.03	259.65	221.80	249.71
Tax	66.72	82.59	93.44	77.37	80.41
Reported Net Profit	230.75	157.41	166.20	144.42	169.29
Total Value Addition	396.61	341.62	319.10	272.28	227.93
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend	126.67	46.06	36.85	36.85	73.70
Corporate Dividend Tax	20.89	7.83	6.26	6.26	10.34
Per share data (annualised)
Shares in issue (lakhs)	230.31	230.31	230.31	230.31	230.31
Earning Per Share (Rs)	100.19	68.35	72.16	62.71	73.51
Equity Dividend (%)	550.00	200.00	160.00	160.00	320.00
Book Value (Rs)	434.79	398.67	353.72	300.28	257.08



Source : Dion Global Solutions Limited
Explore Aventis Pharma connections

Results of Aventis Pharma

News
Results
Estimates
Analysis

23.11.2011
Sell Aventis Pharma; target Rs 1937: Angel Broking

More �

Results of Pharmaceuticals Sector

News
Results
Estimates
Analysis

14.02.2012
Buy Dr Reddys Laboratories; target of Rs 1,920: Angel

14.02.2012
Wockhardt gets US FDA nod; stock at 52-week high

14.02.2012
Reduce Dishman Pharma; target of Rs 61: KRChoksey

14.02.2012
Cipla Dec '11 sales at Rs 1,758.00 crore

More �

Quick Links for aventispharma

Corporate Action
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends

Related Searches aventispharma Stock Price, Aventis%20Pharma Stock Quote, Aventis%20Pharma Results , Aventis%20Pharma News .. More »

Follow moneycontrol.com

Explore Moneycontrol

Stocks A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Mutual Funds A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.